+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Screening for colorectal cancer: possible improvements by risk assessment evaluation?



Screening for colorectal cancer: possible improvements by risk assessment evaluation?



Scandinavian Journal of Gastroenterology 46(11): 1283-1294



Emerging results indicate that screening improves survival of patients with colorectal cancer. Therefore, screening programs are already implemented or are being considered for implementation in Asia, Europe and North America. At present, a great variety of screening methods are available including colono- and sigmoidoscopy, CT- and MR-colonography, capsule endoscopy, DNA and occult blood in feces, and so on. The pros and cons of the various tests, including economic issues, are debated. Although a plethora of evaluated and validated tests even with high specificities and reasonable sensitivities are available, an international consensus on screening procedures is still not established. The rather limited compliance in present screening procedures is a significant drawback. Furthermore, some of the procedures are costly and, therefore, selection methods for these procedures are needed. Current research into improvements of screening for colorectal cancer includes blood-based biological markers, such as proteins, DNA and RNA in combination with various demographically and clinically parameters into a "risk assessment evaluation" (RAE) test. It is assumed that such a test may lead to higher acceptance among the screening populations, and thereby improve the compliances. Furthermore, the involvement of the media, including social media, may add even more individuals to the screening programs. Implementation of validated RAE and progressively improved screening methods may reform the cost/benefit of screening procedures for colorectal cancer. Therefore, results of present research, validating RAE tests, are awaited with interest.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055671370

Download citation: RISBibTeXText

PMID: 21854094

DOI: 10.3109/00365521.2011.610002


Related references

Screening of average-risk individuals for colorectal cancer and postoperative evaluation of patients with colorectal cancer. Surgical Clinics of North America 76(1): 35-45, 1996

Risk assessment and screening for colorectal cancer. Cancer ChemoTherapy and Biological Response Modifiers 21: 747-757, 2003

Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. Annals of Internal Medicine 161(8): 537-545, 2014

Can an online risk assessment tool for identification of hereditary colorectal cancer reach the at-risk population and influence screening compliance?. Deutsche Medizinische Wochenschrift 139(18): 935-940, 2014

Colorectal cancer screening is cost-effective in the elderly who have had less intense prior screening, high baseline risk of colorectal cancer and less comorbidities. Evidence-BasedMedicine21(5):182, 2016

Genetic and environmental risk assessment and colorectal cancer screening. Annals of Internal Medicine 162(7): 526-527, 2015

Rates and predictors of colorectal cancer screening by race among motivated men participating in a Prostate Cancer Risk Assessment Program. Cancer 118(2): 478-484, 2012

Improving the quality of colorectal cancer screening: assessment of familial risk. Digestive Diseases and Sciences 55(3): 754-760, 2010

Screening for colorectal cancer with quantitative risk assessment and rpha fob test. Journal of Cancer Research & Clinical Oncology 116(Suppl. Part 1): 131, 1990

Risk assessment and clinical decision making for colorectal cancer screening. Health Expectations 18(5): 1327-1338, 2015

The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer). Zeitschrift für Gastroenterologie 44(11): 1127-1134, 2006

Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes and Control 16(7): 865-875, 2005

Effects of genetic and environmental risk assessment feedback on colorectal cancer screening adherence. Journal of Behavioral Medicine 38(5): 777-786, 2015

Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort. European Journal of Gastroenterology and Hepatology 27(12): 1433-1437, 2015